Natera Obtains Z-Codes for Signatera MRD and Treatment Monitoring Test in Oncology
5 January 2019
Natera, Inc., a global leader in non-invasive genetic testing and cell-free DNA, today announced the assignment of two Z-codes for the company's Signatera™ test, in preparation for its pl
